Louisiana State Employees Retirement System Halozyme Therapeutics, Inc. Transaction History

Louisiana State Employees Retirement System

$5.54 Billion
Q4 2025

A detailed history of Louisiana State Employees Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Louisiana State Employees Retirement System holds 32,500 shares of HALO stock, worth $2.28 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

32,500

Previous 32,600 0.31%

Holding current value

$2.28 Million

Previous $2.39 Million 4.81%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 16, 2026	SELL	$64.1 - $74.94 $6,409 - $7,494	-100 Reduced 0.31%	32,500 $2.28 Million
Q3 2025 Oct 22, 2025	SELL	$52.92 - $78.28 $111,132 - $164,388	-2,100 Reduced 6.05%	32,600 $2.39 Million
Q2 2025 Jul 23, 2025	SELL	$47.91 - $70.14 $43,119 - $63,126	-900 Reduced 2.53%	34,700 $1.81 Million
Q1 2025 May 01, 2025	BUY	$47.74 - $65.16 $14,322 - $19,548	300 Added 0.85%	35,600 $2.27 Million
Q4 2024 Jan 29, 2025	BUY	$42.57 - $61.09 $8,514 - $12,218	200 Added 0.57%	35,300 $1.69 Million

Q3 2024 Oct 23, 2024	SELL	$51.3 - $64.42 $46,170 - $57,978	-900 Reduced 2.5%	35,100 $2.01 Million
Q2 2024 Jul 24, 2024	SELL	$37.81 - $52.4 $75,620 - $104,800	-2,000 Reduced 5.26%	36,000 $1.88 Million
Q1 2024 Apr 23, 2024	BUY	$33.68 - $41.95 $30,312 - $37,755	900 Added 2.43%	38,000 $1.55 Million
Q4 2023 Jan 29, 2024	SELL	$33.32 - $42.1 $9,996 - $12,630	-300 Reduced 0.8%	37,100 $1.37 Million
Q3 2023 Oct 17, 2023	SELL	$36.46 - $44.03 $40,106 - $48,433	-1,100 Reduced 2.86%	37,400 $1.43 Million
Q2 2023 Jul 18, 2023	BUY	$30.28 - $38.74 $78,728 - $100,724	2,600 Added 7.24%	38,500 $1.39 Million
Q1 2023 Apr 19, 2023	SELL	$32.86 - $55.7 $9,858 - $16,710	-300 Reduced 0.83%	35,900 $1.37 Million
Q4 2022 Jan 24, 2023	SELL	$40.06 - $59.44 $20,030 - $29,720	-500 Reduced 1.36%	36,200 $2.06 Million
Q3 2022 Oct 19, 2022	BUY	$38.53 - $51.78 $19,265 - $25,890	500 Added 1.38%	36,700 $1.45 Million
Q2 2022 Jul 20, 2022	SELL	$37.35 - $48.3 $26,145 - $33,810	-700 Reduced 1.9%	36,200 $1.81 Million
Q1 2022 Apr 22, 2022	BUY	$31.97 - $41.06 $22,379 - $28,742	700 Added 1.93%	36,900 $1.6 Million
Q4 2021 Jan 14, 2022	SELL	$31.82 - $40.75 $3,182 - $4,075	-100 Reduced 0.28%	36,200 $1.46 Million
Q3 2021 Oct 12, 2021	BUY	$38.47 - $46.42 $61,552 - $74,272	1,600 Added 4.61%	36,300 $1.48 Million
Q2 2021 Jul 16, 2021	BUY	$38.84 - $51.31 $66,028 - $87,227	1,700 Added 5.15%	34,700 $1.58 Million
Q1 2021 Apr 14, 2021	BUY	$39.51 - $51.45 $47,412 - $61,740	1,200 Added 3.77%	33,000 $1.38 Million
Q4 2020 Jan 11, 2021	BUY	$25.81 - $43.62 $820,758 - $1.39 Million	31,800 New	31,800 $1.36 Million

Others Institutions Holding HALO

# of Institutions

665

Shares Held

128M

Call Options Held

599K

Put Options Held

455K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account

Louisiana State Employees Retirement System Halozyme Therapeutics, Inc. Transaction History